| Mr Marc Bolland
| Marc J. Bolland, 52, Chief Executive Officer of Marks and Spencer Group plc. since May 2010. Chief Executive Officer of Wm Morrisons Supermarket Plc from September 2006 to April 2010. Executive Board Member of Heineken N.V., a Dutch beer brewing and bottling company, from 2001 to August 2006. Independent Director of Coca-Cola Co. Previously, a Managing Director of Heineken Export Group Worldwide, a subsidiary of Heineken N.V., from 1999 to 2001, and Heineken Slovensko, Slovakia, a subsidiary of Heineken N.V., from 1995 to 1998. A director of ManpowerGroup for more than five years. No other public directorships in the past five years. |
| Mr Klaus-Christian Kleinfeld
| Dr Klaus-Christian Kleinfeld is a director at Hewlett-Packard Co since July 16, 2014. Mr Kleinfeld also is a director at Morgan Stanley since May 2012. He is Chairman and Chief Executive Officer of Alcoa since April 2010. He was President and Chief Executive Officer of Alcoa from May 2008 to April 2010. Mr Kleinfeld was President and Chief Operating Officer of Alcoa from October 2007 to May 2008. He is Chairman of the Executive Committee and of the International Committee of the Board of Directors. Before Alcoa, Mr Kleinfeld had a 20-year career with Siemens, the global electronics and industrial conglomerate, based in the U.S. and Germany, where he served as Chief Executive Officer of Siemens AG from January 2005 to June 2007. Prior to his service on the Managing Board of Siemens AG from 2004 to January 2005, Mr Kleinfeld was President and Chief Executive Officer of the U.S. subsidiary, Siemens Corporation, which represents the company’s largest region, from 2002 to 2004. As the only management representative on our board, Mr Kleinfeld provides an insider’s perspective in board discussions about the business and strategic direction of the Company and has experience in all aspects of the Company’s global business. In addition to serving on Alcoa’s board, he is a member of the Supervisory Board of Bayer AG. He was elected to the Brookings Institution Board of Trustees in May 2010. In September 2009, Mr Kleinfeld was appointed Chairman of the U.S.-Russia Business Council, which is dedicated to promoting trade and investment between the United States and Russia. Mr Kleinfeld was born in Bremen, Germany, and educated at the University of Goettingen and University of Wuerzburg. He holds a PhD in strategic management and a master’s degree in business administration. |
| Mr Ryosuke Tamakoshi
| Mr Ryosuke Tamakoshi is a director at Morgan Stanley since July 20, 2011. Mr Tamakoshi has served as a Senior Advisor of The Bank of Tokyo-Mitsubishi UFJ, Ltd. (BTMU) since 2010. Mr Tamakoshi served as Chairman of MUFG from 2005 to 2010 and as Deputy Chairman of The Bank of Tokyo-Mitsubishi UFJ, Ltd. from 2006 to 2008. Before the merger between Mitsubishi Tokyo Financial Group and UFJ Holdings, Mr Tamakoshi was President and Chief Executive Officer of UFJ Holdings, Inc. and also Chairman of UFJ Bank, Ltd. Mr Tamakoshi began his professional career at The Sanwa Bank, one of the legacy banks of BTMU, in 1970. Other Directorships in the Past Five Years: Mitsubishi UFJ Financial Group, Inc. |
| Ms Ruth Porat
| Ruth Porat, Executive Vice President and Chief Financial Officer of Morgan Stanley (since January 2010). Vice Chairman of Investment Banking (September 2003 to December 2009). Global Head of Financial Institutions Group (September 2006 to December 2009) and Chairman of the Financial Sponsors Group (July 2004 to September 2006) within the Investment Banking Division. |
| Mr Masaaki Tanaka
| Mr Masaaki Tanakaa director of Morgan Stanley since May 18, 2011. Mr Tanaka is the Managing Executive Officer and Chief Executive Officer for the Americas of The Bank of Tokyo–Mitsubishi UFJ, Ltd., a position he assumed in July 2010. From May 2007 to July 2010, Mr. Tanaka was President and Chief Executive Officer of UnionBanCal Corporation and its primary subsidiary Union Bank, N.A., where he continues to serve as a director. In 2007, he was also named a Managing Executive Officer of BTMU. From 1996 to 2004, Mr. Tanaka served in various capacities in the Corporate Planning Division of The Bank of Tokyo-Mitsubishi, Ltd. (BTM). Following the merger of BTM and UFJ Bank, Ltd., which created BTMU, he served as Executive Officer and General Manager of the Corporate Planning Division for the newly combined bank from 2006 to 2007. At BTM, Mr. Tanaka was Executive Officer and General Manager of the Corporate Banking Division with responsibility for relationships with leading corporations. He was also General Manager of the Corporate Business Development Division where he directed strategic planning and coordination of the company’s corporate banking business. Mr. Tanaka began his professional career at the Mitsubishi Bank, a predecessor to BTMU, in 1977 and has over 34 years experience in the banking industry. Other current directorships: UnionBanCal Corporation. |
| Mr James P. Gorman
| Mr James P. Gorman has served as Chairman of the Board since 2012, President and Chief Executive Officer of Morgan Stanley since 2010, and Chairman of Morgan Stanley Smith Barney Holdings LLC since 2009. He was Co-President of Morgan Stanley from 2007 to 2009, Co-Head of Strategic Planning from 2007 to 2009 and President and Chief Operating Officer of the Global Wealth Management Group from 2006 to 2008. Mr. Gorman joined Merrill Lynch & Co., Inc. in 1999 and served in various positions including Chief Marketing Officer, Head of Corporate Acquisitions Strategy and Research in 2005 and President of the Global Private Client business from 2002 to 2005. Prior to joining Merrill Lynch, he was a senior partner at McKinsey & Co., serving in the firm’s financial services practice. Earlier in his career, Mr. Gorman was an attorney in Australia. Other Directorships in the Past Five Years: MSCI Inc. |
| Ms Hutham Bint Suliman Saleh Al Olayan
| Ms Hutham Bint Suliman Saleh Al Olayan is a director of Morgan Stanley since 2006. Ms Olayan is the Chairman of The Olayan Group, a private multinational enterprise that is a diversified global investor and operator of commercial and industrial businesses in Saudi Arabia. operations for more than 20 years, overseeing all investment activity originating in the Americas. Ms Olayan is a member of the International Advisory Board of The Blackstone Group, a director of Equity International and a former director of Thermo Electron Corporation. and Board Member at Technical Trading Co. She also owns a stake in Olayan Investments Company Establishment. |
| Thomas Maddison
| Tom Maddison is vice president of human resources for Xerox Corporation. He was named to this position in February 2010. Maddison is also a vice president of the corporation, appointed on July 15, 2010. Maddison is responsible for the company’s human resource planning, sourcing, talent management, leadership development, pay and rewards, diversity, work environment and industrial relations. Since joining Xerox in 1992, Maddison has held a variety of positions in finance, operations, business services, marketing, and HR management. He served as director of group resources and enterprise marketing in the United Kingdom and as vice president of human resources for Developing Markets Operations. Maddison in 1991 earned his masters degree in industrial design engineering from the Royal College of Art and Imperial College in the United Kingdom and a bachelor of science degree in materials engineering from Loughborough University of Technology in the United Kingdom in 1986. |
| Mr Richard Harrington
| Mr Richard J. Harrington is an independent director at Aetna Inc since September 26, 2008. He served as President and Chief Executive Officer of The Thomson Corporation (business technology and integrated information solutions) prior to its acquisition of Reuters Group PLC in April 2008. From April 2008 to October 2009, he served as Chairman of the Thomson Reuters Foundation. He currently serves as Chairman of The Cue Ball Group (a venture capital firm) and Knovel Corporation (web-based application integrating technical information). Mr. Harrington held a number of senior leadership positions within Thomson since 1982, including CEO of Thomson Newspapers, and CEO of Thomson Professional Publishing. Mr. Harrington began his professional career with Arthur Young & Co. (public accounting firm) in 1972, where he became a licensed certified public accountant. In 2002, he was presented an Honorary Doctorate of Laws from University of Rhode Island. In 2007, he received the “Legend in Leadership” award from the Yale University Chief Executive Leadership Institute; the “CEO of the Year” award from the Executive Council; and the “Man of the Year” award from the National Executive Council for his many philanthropic activities. Mr. Harrington is a director of Xerox Corporation (document management, technology and service enterprise). He is also a director of Milliken & Co. |
| Andrew Billman
| July 13, 2011--Worthington Industries, Inc. (NYSE:WOR) announced today that Andrew Billman will become the next president of Worthington Cylinders, replacing Harry Goussetis who is retiring at the end of July. Billman has been with the Company in various positions for more than 15 years, most recently as the vice president of corporate purchasing. Billman began with Worthington Steel in inside sales, later becoming a territory manager, and manager of special accounts. He gained experience outside of Worthington beginning in 2001 when he was vice president of sales and marketing for a private manufacturer. He managed a facility and served as the company’s vice president of operations. He returned to Worthington Steel in 2006 as national account manager and then as the east region sales manager in Baltimore, where the Company launched the transformation initiative in the steel processing segment. He was an integral part of the transformation. Billman became the head of corporate purchasing in January of 2010. |
| Mr Harish Manwani
| Harish Manwani has served as a director of the Company since May 2014. Mr. Manwani was the Chief Operating Officer for Unilever PLC, a leading global consumer products company, from September 2011 to December 2014. He served as Unilever's President, Asia, Africa, Middle East and Turkey, which was later extended to include Central and Eastern Europe, from April 2005 to August 2011. He served as Unilever's President, Home & Personal Care, North America from March 2004 to March 2005. He served as Unilever's President, Home & Personal Care, Latin America and as the Chairman of Unilever's Latin America Advisory Council from April 2001 to February 2004. He served as Unilever's Senior Vice President, Global Hair and Oral Care from June 2000 to March 2001 |
| Mr Paul Bisaro
| Mr. Paul M. Bisaro serves as Executive Chairman of the Board of Actavis PLC. Bisaro had previously served as President and CEO of Actavis plc, and Chairman of the Board, since October 2013. He was named President and Chief Executive Officer and a member of the Company's Board of Directors in 2007. Prior to joining Actavis, Inc., Mr. Bisaro was President, Chief Operating Officer and a member of the Board of Directors of Barr Pharmaceuticals, Inc., a global specialty pharmaceutical company ("Barr"), from 1999 to 2007. Between 1992 and 1999, Mr. Bisaro served as General Counsel of Barr, and from 1997 to 1999 served in various additional capacities including Senior Vice President — Strategic Business Development. Prior to joining Barr, he was associated with the law firm Winston & Strawn and a predecessor firm, Bishop, Cook, Purcell and Reynolds from 1989 to 1992. Mr. Bisaro holds an undergraduate degree in General Studies from the University of Michigan and a Juris Doctor from Catholic University of America in Washington, D.C. |
| Charles Mayr
| Charles M. Mayr was appointed Chief Communications Officer – Global. Mr. Mayr, age 55, was previously appointed Senior Vice President, Corporate Affairs of Watson effective September 2009. Prior to joining Watson, Mr. Mayr operated an advertising and public relations consulting company, serving such clients as Watson, the Generic Pharmaceuticals Association, Barr Pharmaceuticals, Inc. and a variety of professional associations and consumer products and service companies. Prior to starting his consultancy business, he served as director of corporate communications for Barr. Prior to joining Barr, he served as director of global communications for Sterling Drug Inc., the global brand and consumer health products pharmaceutical subsidiary of Kodak. Mr. Mayr began his career as a broadcast and print journalist and has a B.A. in journalism from New York University. |
| Mr Christopher Bodine
| Mr. Bodine has been a Director of the Company since 2011. Mr. Bodine retired from CVS Caremark Corporation in January 2009 after 24 years with CVS. Prior to his retirement, Mr. Bodine served as President, Healthcare Services of CVS Caremark, where he was responsible for strategy, business development, trade relations, sales and account management, pharmacy merchandising, marketing, information technology and Minute Clinic. Prior to the merger of CVS Corporation and Caremark Rx, Inc. in March 2007, Mr. Bodine served for several years as Executive Vice President —Merchandising and Marketing of CVS Corporation. Mr. Bodine has served as a Director of Watson Pharmaceutical since June, 2009, and since 2009 has served as the Chairman of Songbird Hearing, Inc. In addition, Mr. Bodine has been active in the pharmaceutical industry serving on a number of boards and committees, including the Healthcare Leadership Council, RI Quality Institute, National Retail Federation, National Association of Chain Drug Stores (NACDS), and the NACDS Pharmacy Affairs and Leadership Committees. |
| Mr Fred Weiss
| Mr. Fred G. Weiss , age 73 , serves as an Independent Director of Actavis, PLC. Mr. Weiss served as a member of Actavis, Inc.’s Board of Directors since 2000 and joined our Board of Directors in October 2013. Mr. Weiss is currently the managing director of the consulting firm FGW Consultancy LLC and was previously the managing director of FGW Associates, Inc., a position he held since 1997. Prior to that he served as an executive for Warner-Lambert for nearly 20 years, most recently as Vice President, Planning, Investment and Development. Mr. Weiss is also an Independent Vice-Chairman of the Board and Chairman of the Audit Committee of numerous BlackRock-sponsored mutual funds. In this capacity, and pursuant to BlackRock’s policies, Mr. Weiss has oversight responsibility for finance and accounting matters, and has no responsibility for, or discretion concerning, any of BlackRock’s equity investment decisions. Additionally, Mr. Weiss has been a Director of the Michael J. Fox Foundation for Parkinson’s Research since 2000 and serves as the Chair of the Finance Committee. |
| R. Joyce
| R. Todd Joyce was appointed Chief Financial Officer- Global. Mr. Joyce, age 54, was previously appointed Executive Vice President, Chief Financial Officer of Watson on March 9, 2011. Mr. Joyce served as Senior Vice President, Chief Financial Officer from October 2009 to March 2011. Mr. Joyce joined Watson in 1997 as Corporate Controller, and was named Vice President, Corporate Controller and Treasurer in 2001. During the periods October 2006 to November 2007 and from July 2009 until his appointment as Chief Financial Officer, Mr. Joyce served as interim Principal Financial Officer. Prior to joining Watson, Mr. Joyce served as Vice President of Tax from 1992 to 1996 and as Vice President of Tax and Finance from 1996 until 1997 at ICN Pharmaceuticals. Prior to ICN Pharmaceuticals, Mr. Joyce served as a Certified Public Accountant with Coopers & Lybrand and Price Waterhouse. Mr. Joyce received a B.S. in Business Administration from the University of North Carolina at Chapel Hill in 1983 and a M.S. in Taxation from Golden State University in 1992. |
| Ms Catherine Klema
| Catherine M. Klema, age 53, is currently President of Nettleton Advisors LLC, a consulting firm established by Ms. Klema in 2001. Ms. Klema served as Managing Director, Healthcare Investment Banking, at SG Cowen Securities from 1997 to 2001. While at SG Cowen, Ms. Klema had advised us on investment banking matters. Ms. Klema also served as Managing Director, Healthcare Investment Banking, at Furman Selz LLC from 1994 until 1997, and was employed by Lehman Brothers from 1987 until 1994. Ms. Klema served as a director of Pharmaceutical Product Development, Inc., a global contract research organization, from 2000 – 2011. In March 2012, Ms. Klema was appointed to the Montefiore Medical Center Board of Trustees. The Board concluded that Ms. Klema’s qualifications for service on our Board include her background in healthcare investment banking and her knowledge of the business of pharmaceutical research and development. Also she is a director at Allergan Inc. |
| Mr Donald Graham
| Donald E. Graham has served as a member of our board of directors since March 2009. Mr. Graham has served as the Chief Executive Officer of The Washington Post Company, an education and media company, since 1991 and as Chairman of its board of directors since 1993. Mr. Graham holds an A.B. in English history and literature from Harvard University, He served as the Lead Independent Director of Facebook, Inc. until June 11, 2015 |
| Ms Sheryl Kara Sandberg
| Sheryl K. Sandberg has served as our Chief Operating Officer since March 2008. From November 2001 to March 2008, Ms. Sandberg served in various positions at Google, Inc., most recently as Vice President, Global Online Sales & Operations. Ms. Sandberg also is a former Chief of Staff of the U.S. Treasury Department and previously served as a consultant with McKinsey & Company, a management consulting company, and as an economist with The World Bank. In addition to serving as our Chief Operating Officer, Ms. Sandberg has been a member of the board of directors of the Walt Disney Company since December 2009. Ms. Sandberg holds an A.B. in economics from Harvard University and an M.B.A. from Harvard Business School. On June 24, 2012, the Board of Directors of Facebook, Inc. appointed Sheryl K. Sandberg, the Company’s Chief Operating Officer, as a member of the Board. |
| Mr Robert Allen Iger
| Mr Robert A. Iger is Chairman and Chief Executive Officer of The Walt Disney Co. Prior to his current role, Mr. Iger served as President and Chief Executive Officer beginning of October 2005 and President and Chief Operating Officer from 2000-2005. Mr. Iger officially joined the Disney senior management team in 1996 as Chairman of the Disney-owned ABC Group and in 1999 was given the additional responsibility of President, Walt Disney International. Mr. Iger joined the Apple board of directors in November 2011 and became a board member of the U.S.-China Business Council in June 2011. He also serves on the boards of the National September 11 Memorial & Museum and the Lincoln Center for the Performing Arts, Inc. In June 2010, President Barack Obama appointed him to the President’s Export Council, which advises the President on how to promote U.S. exports, jobs, and growth. Mr. Iger is also a member of the Partnership for a New American Economy, a coalition of mayors and business leaders from across the United States that supports comprehensive immigration reform. In 2012, Mr. Iger became a member of the Academy of Arts & Sciences, one of the nation’s most prestigious honorary societies, which recognizes some of the world’s most accomplished scholars, scientists, writers, artists, and civic, corporate, and philanthropic leaders. Mr. Iger is a graduate of Ithaca College. |
